Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Unraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research models.

NPJ Parkinson's disease·2026

Same author

Vein of Galen aneurysmal malformation affecting cotwin in dichorionic diamniotic pregnancy.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020

Same author

Severe underquantification of HIV-1 group O isolates by major commercial PCR-based assays.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

Same author

Introduction: DRIVE-AB's definitions and indicators to monitor responsible antibiotic use.

The Journal of antimicrobial chemotherapy·2018

Same author

Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon.

Virology·2017

Same author

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

The Journal of antimicrobial chemotherapy·2015

Search research articles

Related Experiment Video

Updated: Jul 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Naturally occurring sequence polymorphisms within HIV type 1 group O protease.

K C Luk¹, L Kaptué, L Zekeng

¹AIDS Research and Retrovirus Discovery, Abbott Laboratories, Abbott Park, Illinois 60064, USA.

AIDS Research and Human Retroviruses

|November 16, 2001

Summary

This summary is machine-generated.

HIV-1 group O protease genes show natural polymorphisms, not primary resistance mutations. These secondary mutations may accelerate drug resistance and treatment failure in group O patients.

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Related Experiment Videos

Last Updated: Jul 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Area of Science:

Virology
Molecular Biology
Infectious Diseases

Background:

Protease inhibitor resistance mutations are documented in HIV-1 group M subtype B.
Limited genotypic and phenotypic data exist for HIV-1 group O strains.
Preexisting polymorphisms in group O may impact antiviral treatment response.

Purpose of the Study:

To identify naturally occurring amino acid polymorphisms associated with drug resistance in the protease gene of protease inhibitor-naive HIV-1 group O.
To compare group O protease sequences with subtype B of group M.

Main Methods:

Analysis of protease genes from 28 protease inhibitor-naive HIV-1 group O-infected patients.
Comparison of consensus group O protease sequence with subtype B of group M.

Main Results:

Group O and subtype B protease sequences are nearly identical in key active site regions.
34% of protease gene positions showed polymorphisms in group O strains, but no primary resistance mutations were found.
All group O strains possessed multiple secondary/accessory mutations linked to protease inhibitor resistance in group M.

Conclusions:

Naturally occurring polymorphisms in HIV-1 group O protease genes do not include primary resistance mutations.
The presence of multiple secondary resistance-associated mutations in group O may facilitate rapid development of drug resistance phenotypes.
These findings suggest a potential for faster treatment failure in group O-infected patients.